Management of Treatment-Experienced HIV-Infected Patients

  • Author: Eric S. Daar, MD (More Info)
  • Section Editor: Eric S. Daar, MD
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 7/16/19 (What's New)

Summary

  • Ibalizumab-uiyk FDA approved in 2018 for use in combination with other ARV agents in heavily treatment–experienced patients with multidrug resistance who are experiencing failure of their current ART regimen

Action required